VaramirStart free · no cardSign in
DNLI as of Nov 3 · 13:02 ET
DNLINasdaqBiological Products, (No Diagnostic Substances)

Denali Therapeutics Inc. · Brief

Next report

2 days

Nov 5 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±13.1%
avg realized
±3.1%
Nov 6 '24±7.6%▲+0.17%×0.02
Feb 27 '25±16.6%▼−10.97%×0.66
May 6 '25±15.9%▲+2.51%×0.16
Aug 11 '25±11.9%▼−5.03%×0.42
Q3 FY25±16.4%▲+4.23%×0.26
Q1 FY26±14.9%▼−1.12%×0.08
May 7 '26±11.8%▼−0.46%×0.04
Q2 FY26±9.8%▲+0.40%×0.04
quarterimplied−20%0+20%realized×
Q2 FY26±9.8%▲+0.40%×0.04
May '26±11.8%▼−0.46%×0.04
Q1 FY26±14.9%▼−1.12%×0.08
Q3 FY25±16.4%▲+4.23%×0.26
Aug '25±11.9%▼−5.03%×0.42
May '25±15.9%▲+2.51%×0.16
2 older reports
Feb '25±16.6%▼−10.97%×0.66
Nov '24±7.6%▲+0.17%×0.02
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2

13disclosed supplier and customer ties in SEC filingsSEC filings
296managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

8 of 8recent reports where the move came in under the options implied rangeEarnings history
7 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

DNLI report session

Suppliers 1

BIIBBiogen×0.19
× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±17.4% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.